FDA Approves Groundbreaking Oral Drug for Advanced Pancreatic Cancer
The U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib (sold as Rasonque), a first-of-its-kind daily oral medication for adults with advanced metastatic pancreatic ductal adenocarcinoma. Developed by ... Read More